Study of TAK-071 in Healthy Participants and Participants With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability (BA) and Food Effect of TAK-071 in Healthy Participants

PHASE1TerminatedINTERVENTIONAL

Enrollment

179

Participants

Timeline

Start Date

May 5, 2016

Primary Completion Date

June 8, 2017

Study Completion Date

June 8, 2017

Conditions

Alzheimer DiseaseHealthy Volunteers

Interventions

DRUG

TAK-071

TAK-071 capsules

DRUG

Donepezil

Donepezil over-encapsulated tablet

DRUG

TAK-071 Placebo

TAK-071 placebo-matching capsules

DRUG

Donepezil Placebo

Donepezil placebo-matching over-encapsulated tablet

Trial Locations (1)

Glendale